Ketamine: reclassification alone will not reduce harms

Without parallel public health action, reclassifying ketamine risks being a symbolic gesture rather than a strategy to reduce harm, write <b>Adam Winstock</b>, <b>David Nutt</b>, and <b>Caroline Copeland</b>

Authors

Institutions

Publication Details

Journal
BMJ
Published
2026-02-03
DOI
https://doi.org/10.1136/bmj.s222
Primary Topic
Treatment of Major Depression
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Ketamine: reclassification alone will not reduce harms

Caroline Copeland, Adam Winstock, David J Nutt
BMJ
Treatment of Major Depression
article

Ketamine: reclassification alone will not reduce harms

Caroline Copeland, Adam Winstock, David J Nutt
article en

Abstract

Without parallel public health action, reclassifying ketamine risks being a symbolic gesture rather than a strategy to reduce harm, write <b>Adam Winstock</b>, <b>David Nutt</b>, and <b>Caroline Copeland</b>

BMJVol. 392
King's College London (GB), HM Prison and Probation Service (GB), University College London (GB), Imperial College London (GB)
Openalex Percentile: Top 67%
Treatment of Major Depression
DOIOpen Access PDFOpenAlex
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.